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In response to DNA damage, eukaryotic cells activate a series
of DNA damage-dependent pathways that serve to arrest cell
cycle progression and remove DNA damage. Coordination of
cell cycle arrest and damage repair is critical for maintenance of
genomic stability. However, this process is still poorly understood. Nucleotide excision repair (NER) and the ATR-dependent cell cycle checkpoint are the major pathways responsible for
repair of UV-induced DNA damage. Here we show that ATR
physically interacts with the NER factor Xeroderma pigmentosum group A (XPA). Using a mass spectrometry-based protein
footprinting method, we found that ATR interacts with a helixturn-helix motif in the minimal DNA-binding domain of XPA
where an ATR phosphorylation site (serine 196) is located. XPAdeficient cells complemented with XPA containing a point
mutation of S196A displayed a reduced repair efficiency of
cyclobutane pyrimidine dimers as compared with cells complemented with wild-type XPA, although no effect was observed for
repair of (6-4) photoproducts. This suggests that the ATR-dependent phosphorylation of XPA may promote NER repair of
persistent DNA damage. In addition, a K188A point mutation of
XPA that disrupts the ATR-XPA interaction inhibits the
nuclear import of XPA after UV irradiation and, thus, significantly reduced DNA repair efficiency. By contrast, the S196A
mutation has no effect on XPA nuclear translocation. Taken
together, our results suggest that the ATR-XPA interaction
mediated by the helix-turn-helix motif of XPA plays an important role in DNA-damage responses to promote cell survival and
genomic stability after UV irradiation.

The genomes of all living cells are under constant attack from
both endogenous and exogenous agents that may lead to
genome instability. The nucleotide excision repair pathway
(NER)3 is the primary mechanism in cells for the removal of
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bulky DNA lesions induced by exogenous agents such as UV
radiation and a variety of genotoxic chemicals (1). In eukaryotic
cells NER requires more than 25 proteins to perform the DNA
damage recognition, excision, and DNA synthesis steps necessary to remove the lesion and restore the integrity of DNA (2, 3).
In humans, defects in NER lead to the clinical disorder Xeroderma pigmentosum (XP) that is characterized by increased
sensitivity to UV light and a predisposition to development of
skin cancer (4, 5).
Xeroderma pigmentosum group A protein (XPA) is one of
eight factors found to be deficient in XP disorder (2, 3, 6). XPA
is a 32-kDa zinc metalloprotein that is believed to verify the
damage site after initial recognition of the presence of a lesion,
stabilize repair intermediates, and play a role in recruiting other
NER factors (7–13). XPA is an indispensable factor for both the
transcription-coupled repair and global genome NER pathways. Given its central role in NER, patients with XPA deficiency display the most severe XP phenotypes (2, 3). In addition, XPA has also been implicated to play a role in
laminopathy-induced premature aging syndromes (14, 15).
The DNA damage checkpoint pathways serve to monitor
genomic integrity and to coordinate multiple cellular pathways
to ensure efficient repair of DNA damage (16). The ATM (ataxia-telangiectasia mutated) and ATR (ATM and RAD3-related)mediated checkpoint pathways represent two major DNA
damage-dependent checkpoints. Both ATM and ATR are protein kinases belonging to the phosphoinositide 3-kinase-like
kinase family. These pathways are composed of a series of DNA
damage sensors, signal mediators and transducers, and downstream effector molecules (1, 16, 17). The ATR-dependent
checkpoint pathway serves to sense replication stress and
responds primarily to DNA damage typically generated by UV
irradiation (1, 18 –20). ATR is targeted to the sites of elongated
RPA-coated single-strand DNA generated when DNA replication forks stall because of DNA damage. This event is mediated
by interactions between RPA and the ATR interaction protein
ATRIP (18). Upon sensing DNA damage, ATR initiates a complex
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signaling cascade via phosphorylation of downstream protein substrates, which ultimately leads to cell cycle arrest (20, 21).
Previous studies have implied a role for the ATR-mediated
checkpoint pathway in regulation of the NER pathway (17, 22,
23). In particular, ATR kinase activity may participate in the
regulation of global genome NER uniquely during the S-phase
of the cell cycle. Additionally, XPA has been defined as a direct
ATR target for phosphorylation and cytoplasm-to-nucleus
redistribution in response to UV-C irradiation (22). XPA⫺/⫺
cells complemented with recombinant phosphorylation-deficient XPA protein displayed an increased sensitivity to UV-C
irradiation compared with cells complemented with wild-type
XPA (22). In addition, ATR directed the nuclear import of XPA
in both a dose-dependent and time-dependent manner for regulation of NER activity (17).
Although there is growing evidence that the ATR-dependent
checkpoint pathway coordinates with NER via an ATR-XPA
interaction to promote DNA repair, how the interaction occurs
and its significance have not been defined. Furthermore, the
molecular basis of the ATR-XPA interaction remains to be elucidated. There is no structural information available for the
ATR kinase or a model for how it binds to target proteins. In
this study we investigated the molecular basis for the ATR-XPA
interaction. Using our mass spectrometric protein footprinting
technique, we identified an ␣-helix in the XPA minimum DNAbinding domain that mediates the XPA-ATR interaction. In
addition, we demonstrate that regulation of XPA activity by
ATR via ATR-XPA interaction is required for promoting repair
of UV-C induced DNA damage by NER.

EXPERIMENTAL PROCEDURES
Cell Lines and Tissue Culture—XPA⫺/⫺ cells (GM04429)
were obtained from Coriell Cell Repositories (Camden, NJ) and
were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. XPA-complemented cells were generated by stably
transfecting GM04429 cells with pcDNA3.1 vectors (Invitrogen) containing either wild-type or mutated XPA cDNA with
the indicated point mutations as described previously (22).
U2OS stably transfected with the doxycycline-inducible FLAGtagged ATR expression construct were a generous gift from Dr.
Paul Nghiem (University of Washington Medical Center) and
were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin, 0.2 mg/ml neomycin, and 0.2 mg/ml hygromycin. All
cell lines were grown at 37 °C, 5% CO2. UV-C irradiation was
performed using a 254-nm lamp at a fluence of 1.3 J/m2/s. For
time course analysis cells were incubate at 37 °C, 5% CO2 for the
indicated amounts of time.
FLAG-ATR Immunoprecipitation and ATR-XPA Complex
Formation—U2OS-FLAG-ATR cells were grown overnight in
10-cm tissue culture dishes in Dulbecco’s modified Eagle’s
medium supplemented with doxycycline (5 g/ml). Cells were
harvested by scraping and resuspended in lysis buffer (50 mM
HEPES-KOH, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 1⫻ protease inhibitor mixture (Roche Applied Science)). Clarified lysates were immunoprecipitated using monoclonal mouse-anti-FLAG M2 antibody (Sigma) and captured

24214 JOURNAL OF BIOLOGICAL CHEMISTRY

with Protein G-coated Sepharose beads (Amersham Biosciences). Beads were rinsed with wash buffer A (50 mM
HEPES-KOH, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.05%
NP-20) before washing with high salt buffer (50 mM HEPESKOH, pH 7.4, 1 M NaCl, 1 mM EDTA, 0.05% Nonidet P-40).
Immunoprecipitates then were equilibrated in the XPA-ATR
binding buffer (50 mM HEPES-KOH, pH 7.4, 150 mM NaCl, 1
mM EDTA, 1 mM ATP), and purified His6-XPA was added and
incubated at room temperature for 30 min. Unbound XPA was
washed away using buffer B (50 mM HEPES-KOH, pH 7.4, 150
mM NaCl, 1 mM EDTA, 1 mM ATP, 0.05% Nonidet P-40). The
resulting complex was modified by the addition of NHS-biotin
(1 mM final concentration) for 30 min. The reactions were
quenched with 10 mM lysine in its free form. The interacting
proteins were separated by SDS-PAGE and visualized by Coomassie stain. The XPA bands were excised from the gel and
subjected to in-gel trypsin hydrolysis as described previously
(24, 25).
Mass Spectrometric Analysis—The tryptic peptide fragments
were analyzed with matrix-assisted laser desorption time-offlight (MALDI-TOF) mass spectrometry using an Axima-CRF
instrument (Shimadzu Scientific Instruments). Samples were
ionized with an ␣-cyano-4-hydroxycinnamic acid matrix. To
identify XPA peptide peaks, the experimental data were compared with the theoretical values obtained with Protein Prospector Version 4.0.6. The experimental measurements indicated the mass accuracy of 0.1– 0.01%. Modified lysine residues
were assigned by identifying the peptide peaks formed upon the
NHS-biotin treatment of the protein. The experimental mass/
charge data for modified peptides were then compared with the
predicted theoretical values considering that each modification
adds 226 Da to the affected Lys and renders the residue resistant
to tryptic hydrolysis. For accurate quantitative analysis of the
modified peptide peaks, at least two unmodified proteolytic
peptide peaks were used as internal controls. A protection was
considered to be significant when the intensity of the given
modified peptide peak derived from NHS-biotin-treated free
protein was reduced at least 10-fold in the context of the protein-protein complex. A modified peptide peak was considered
unprotected when the intensities of the given peptide obtained
from free protein and protein-protein complexes were within
⫾20% of each other. The data were reproducibly compiled and
analyzed from at least four independent experimental groups.
Coimmunoprecipitation—Coimmunoprecipitation experiments were conducted by lysing cells with lysis buffer A and
adding dilution buffer to reduce the final NaCl concentration to
150 mM. One mg of total protein was immunoprecipitated
using 2 g of monoclonal mouse-anti-XPA (Clone 12FA,
Kamiya Biochemical). Samples were resolved on a 4 –12% gradient SDS-PAGE for Western blot analysis.
Immunofluorescent DNA Repair Assay—For immunofluorescence microscopy, cells were grown on coverslips and UVC-irradiated through 3- or 5-m polycarbonate isopore filters
(Millipore) and allowed to recover for the indicated amounts of
time. Cells were fixed with 100% methanol and treated with 1 M
HCl to denature the DNA. Cyclobutane pyrimidine dimers
(CPD) or (6-4) photoproducts ((6-4)PPs) were detected with
monoclonal mouse-anti-CPD (TDM-2, MBL International
VOLUME 284 • NUMBER 36 • SEPTEMBER 4, 2009
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then rapidly chilled on ice for 10 min
before adding an equal volume of 2 M
ammonium acetate. Samples were filter-immobilized on a nylon membrane and probed using monoclonal
mouse-anti-CPD.
Subcellular Fractionation—The
subcellular protein fractionation
was performed using the Proteo
JETTM cytoplasmic and nuclear
protein extraction kit (Fermentas)
and by following the procedures as
suggested by the manufacturer.
Briefly, 10 volumes of cell lysis
buffer (with protease inhibitors)
were added to 1 volume of packed
cells. After vortexing for 10 s and
incubation on ice for 10 min, cytoplasmic proteins were separated
from nuclei by centrifugation at
500 ⫻ g for 7 min. Isolated nuclei
FIGURE 1. XPA-ATR complex preparation. A, U2OS-ATR cells were treated with increasing amounts of doxycycline for 24 h to induce expression of the FLAG-ATR construct. Then, cell lysates were mixed with anti-FLAG were washed once with 500 l of the
IgG, and immunoprecipitated proteins were analyzed by Western blot using anti-ATR monoclonal IgG. West- nuclei washing buffer and then colern blot analysis indicates that as the concentration of doxycycline increases, the amount of FLAG-ATR expression also increases, whereas immunoprecipitation of the FLAG-tagged protein results in a single full-length lected by centrifugation. The colprotein. B, FLAG-ATR protein was immunoprecipitated and washed with increasing concentrations of NaCl lected nuclear pellets were resussolution to remove bound proteins. ATRIP forms a tight complex with ATR and is efficiently removed by pended in ice-cold nuclear storage
washing with 1 M NaCl. The ATRIP/ATR ratios were normalized to the ratio at zero salt concentration. C, recom1
binant His6-XPA was immobilized on nickel-nitrilotriacetic acid beads and modified with increasing amounts of buffer, and ⁄10 volume of the nuclear
NHS-biotin (0, 0.1, 0.25, 0.5, and 1 mM) before or after the addition of FLAG-ATR lysates. XPA modified with 1 mM lysis reagents were added to the
NHS-biotin before the addition of FLAG-ATR lysate prevents formation of the XPA-ATR complex; however,
mixtures to lysis the nuclei by shakmodification after complex formation does not affect the protein-protein interaction. A nonspecific (NS) protein band was also observed during the immunoprecipitation even though no XPA was added to the beads, ing for 15 min at 4 °C. Then nuclear
indicating that the protein interacts with the nickel matrix and not with XPA or ATR (data not shown). Because lysate was collected after rinsing by
of the nonspecific nature of the band, it was used as a loading control for these experiments. D, FLAG-ATR
purified by immunoprecipitation was mixed with His6-XPA (lane 3 and 4) and modified with NHS-biotin (lane 4). centrifugation at 20,000 ⫻ g for 12
As control, anti-FLAG antibody was mixed with the recombinant XPA in the absence of ATR protein (lane 5). min.
Protein bands were excised and digested with trypsin for mass spectrometry analysis.
Computational Modeling—An
initial model of phosphorylated
Corporation) or anti-(6-4)PPs (D195–1, MBL) and donkey- XPA was generated from the PDB coordinates 1D4U (26) using
anti-mouse Alexa Fluor 568 antibodies (Molecular Probes). the Biopolymer module of Insight II (Accelrys, Inc., San Diego,
Coverslips were mounted in ProLong Antifade with DAPI CA). Native and phosphorylated XPA structures were subse(Molecular Probes) and visualized using 100⫻ magnification. quently minimized in Amber 9 (27). Electrostatic surfaces were
Data were recorded under single-blind conditions in which the calculated using the APBS plug-in PyMOL (28 –30); atomic
individual performing the microscopy did not know the iden- charge and radius assignments were prepared for the electrotity of the samples. Repair of CPD or (6-4)PPs damage was static calculation using PDB 2PQR (31).
quantified as a percentage of DAPI-stained nuclei containing at
least one well defined CPD or (6-4)PPs focus by overlaying the RESULTS
anti-CPD or anti-(6-4)PPs and DAPI images. At least 50 nuclei
Protein Purification and ATR-XPA Complex Formation—
per time point were counted for damage repair quantification. Recombinant XPA containing an N-terminal His6 tag was purified
Samples then were normalized, with time point 0 h represent- from baculovirus-infected insect cells as described previously (10).
ing 100% nuclei containing CPD or (6-4)PPs foci. Images were Recombinant ATR protein containing an N-terminal FLAG tag
analyzed using Photoshop CS.
was purified from U2OS cells expressing ATR cDNA under the
Slot-blot DNA Damage Repair Assay—Cells were seeded at control of a tetracycline-inducible promoter (32). To obtain the
1 ⫻ 106 cells per 10-cm tissue culture dish and allowed to highest yield of ATR, FLAG-ATR expression was induced by
grow for 48 h before UV-C irradiation. Cells were allowed to tetracycline derivative doxycycline at varying concentrations of
recover for the indicated amounts of time, and genomic DNA 1, 2, and 5 g/ml (Fig. 1A). Whole cell lysates were obtained
was purified using the PureLink Genomic DNA kit (Invitro- followed by immunoprecipitation with FLAG antibody. Analygen). Purified DNA was quantified by measuring the A260 nm, sis of the samples with and without immunoprecipitation by
and samples were diluted to 0.2 g/ml in a final volume of 200 Western blotting of a 3– 8% gradient SDS gel shows that the
l of TE buffer containing 10 mM Tris-HCl, pH 7.4, and 1 mM amount of ATR increases with doxycycline concentration and a
EDTA. Samples were denatured by incubating at 90 °C for 10 min single band of ATR present only in the doxycycline-induced cell
SEPTEMBER 4, 2009 • VOLUME 284 • NUMBER 36
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Although about 30% ATRIP
remained after the 1 M NaCl wash,
the reduction of tightly bound
ATRIP shows the efficiency of the
wash procedure. We also found that
further increasing the salt concentration above 1 M interfered with the
antibody-antigen interaction. The
high salt-washed FLAG-ATR could
then be incubated with purified
recombinant XPA to investigate
complex formation.
Chemical Modification of XPA
and XPA-ATR Complex—Previous
studies demonstrated that ATR can
directly interact with XPA (22). To
map the XPA sites involved in the
interaction with ATR, we used our
mass spectrometry-based protein
footprinting approach (24, 25, 34,
35). The method enables a comparison of surface topologies of the free
protein versus the protein-protein
complex using small chemical modifiers. We chose to use a primary
amine-selective reagent, NHS-biotin, for probing the ATR-XPA interactions given that lysines are one of
the most abundant residues in these
proteins. Furthermore, a similar
experimental approach applied to
other protein-protein interactions
consistently identified physiologically important interactions (24, 25,
34, 35).
For meaningful footprinting experiments, it was essential to
establish mild modification conditions under which the integrity of
the functional protein-protein
complexes would be preserved.
FIGURE 2. MALDI-TOF analysis of biotin-modified XPA. A, a typical MALDI-TOF mass spectrum of peptide For this purpose we carefully optifragments resulting from trypsin digestion of biotin modified XPA. B, summary of MALDI-TOF results in the
context of the XPA primary structure. The sequence of N-terminal His6 tag added for purification of the recom- mized the concentrations of NHSbinant protein is shown. The His6 tag residue numbering begins with ⫺1 and continues backward to the N biotin in the reaction mixtures.
terminus. The initial methionine residue of the XPA sequence is labeled ⫹1. Amino acid sequences correspond- We immobilized recombinant
ing to tryptic peptide fragments detected by MALDI-TOF are depicted in bold. The lysine residues affected by
His6-XPA on nickel-nitrilotriaceNHS-biotin treatment are indicated by arrows.
tic acid beads and modified the
lysates (Fig. 1A). Based on these results, we chose 5 g/ml doxy- protein with increasing amounts of NHS-biotin before or
cycline to induce FLAG-ATR expression. To obtain relatively after the addition of doxycycline-induced U2OS cell lysates
pure ATR for XPA binding, the immunoprecipitated FLAG- to assay the effects of biotinylation on XPA-ATR complex
ATR was washed with a high salt-containing buffer to remove formation. Fig. 1C shows that biotinylation of XPA before
proteins associated with the FLAG-ATR. Because ATR forms a the addition of U2OS lysate prevents the coimmunoprecipitight complex with ATRIP in vivo (33), the presence of ATRIP tation of FLAG-ATR at concentrations greater than 1
coimmunoprecipitated with ATR was monitored with increas- mg/ml. These data suggest that at least one surface lysine in
ing concentrations of NaCl to test the efficiency of the high salt XPA is essential for interactions with ATR. Of note, the identical
wash. Fig. 1B illustrates that as the salt concentration increases treatment of the preformed the XPA-ATR complex did not disto 1 M, the levels of ATRIP co-immunoprecipitated with FLAG- turb the protein-protein complex, indicating the modification
ATR decreases significantly, as detected by Western blotting. conditions were sufficiently mild. These findings defined optimal
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NHS-biotin. In parallel experiments, free XPA was also subjected
to the NHS-biotin treatment. The
modified proteins were then
resolved by SDS-PAGE. Fig. 1D
shows a Coomassie Blue-stained
gel. The unmodified and modified
forms of free XPA are shown in
lanes 1 and 2, respectively. Four
major bands were observed for the
unmodified (lane 3) and NHS-biotin treated (lane 4) XPA-ATR complexes corresponding to ATR, XPA,
and the heavy and light chains of the
FLAG antibody. The XPA bands
were excised from the gel and subjected to in-gel trypsin proteolysis to
generate small peptide fragments
amenable for MALDI-TOF analysis.
Fig. 2A depicts a representative
mass spectrum for tryptic fragments of the modified XPA protein.
Monoisotopic resolution of the
peaks were obtained, allowing us to
reliably identify the tryptic fragments of XPA. Fig. 2B illustrates the
peptide fragments (bold sequences)
and biotinylated lysines identified
by MALDI-TOF analysis.
To identify the XPA surface
lysine(s) interacting with ATR, we
compared the modification profiles
of free XPA and the XPA-ATR complex. Fig. 3 depicts representative
MALDI-TOF fragment profiles
used for comparison. Fig. 3A demonstrates that Lys-188 was readily
susceptible to modification in free
XPA but was inaccessible to NHSbiotin in the XPA-ATR complex.
These results indicate that Lys-188
FIGURE 3. MALDI-TOF analysis of lysine protection in the XPA-ATR complex. A, top and middle spectra show is surface-exposed in free XPA and
free XPA and the XPA-ATR complex treated with NHS-biotin. The bottom spectrum shows untreated free XPA.
The peak corresponding to XPA tryptic peptide fragment amino acids 184 –189 containing a single modified becomes shielded upon ATR bindLys at position 188 is indicated. This peak is detected in free XPA samples and is significantly diminished in the ing. In contrast, Fig. 3B illustrates an
XPA-ATR complex. B, unlike Lys-188, lysine residue 31 is modified in both free XPA and the XPA-ATR complex. m/z peak corresponding to bioPeaks C1, C2, and C3 are unmodified peptide fragments of XPA and serve as internal controls.
tinylated XPA fragment 31–32
(K31⫹biotin) present in the spectra
experimental conditions for subsequent mass spectrometry foot- for both the free XPA and the XPA-ATR complex. These data
suggest that surface topology of Lys-31 is not affected by the
printing of the ATR-XPA complex.
Mass Spectrometric Footprinting of the XPA-ATR Complex— bound ATR. Peaks C1, C2, and C3 are unmodified peptide
To form the protein-protein complex, purified His6-XPA was peaks of XPA and provide internal reference. The lysine footadded in excess to FLAG-ATR immobilized on Protein-G printing results for the XPA-ATR complex are summarized in
beads and incubated in the binding buffer (see “Experimental Table 1.
Lys-188 and the XPA-ATR Interaction—We identified 16
Procedures”). For control experiments, XPA was also incubated
with the Protein-G beads that were preincubated with anti- lysine residues biotinylated in XPA, of which one residue, LysFLAG-treated cell lysates from un-induced U2OS cells under 188, was protected from modification in the presence of ATR
the same experimental conditions. Unbound XPA was then (Table 1). Fig. 4A is a view of the minimum DNA-binding
washed away, and the resulting samples were treated with domain structure of XPA as determined by NMR spectroscopy
SEPTEMBER 4, 2009 • VOLUME 284 • NUMBER 36
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TABLE 1
Summary of MALDI-TOF analysis of biotinylated XPA peptides
Presented are tryptic digest fragments containing biotinylated lysine residues.
Lysine residues protected from modification in the presence of ATR are indicated
by a ⫹, whereas residues not protected by ATR are indicated by a ⫺. The asterisk
indicates that the biotinylated fragment is located in the His tag. The intensity of the
biotinylated peptide peak 184 –189 (Lys-188 ⫹ biotin) was at least 10-fold higher for
free XPA treated with NHS-biotin than for XPA-ATR complex modified under
identical conditions. Intensities of other biotinylated XPA peptide fragments in the
absence and presence of ATR varied within ⫾20%.
Fragment

Modified Lys

Protection

(⫺18)–(⫺5)*
31–32
87–110
136–141
152–158
164–168
184–189
190–207
218–221
216–221
219–224
222–227
223–227
232–237
259–273
260–273

⫺12*
31
89
137
157
167
188
204
218
217, 218
221, 222
222, 224
224
236
259
272

⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺

(PBD code 1D4U) (26). ATR phosphorylates XPA at serine 196
(shown in green), which is located in the turn of a helix-turnhelix motif, a part of the proposed DNA-binding cleft. Protected lysine residue Lys-188 (shown in blue) is also located in
the helix-turn-helix motif and is oriented in nearly the same
plane as Ser-196. This is consistent with the fact that phosphorylation requires binding of ATR to XPA.
Given that Lys-188 is shielded from the solvent in the presence of ATR, site-directed mutagenesis of Lys-188 was performed to investigate its possible role in XPA-ATR complex
formation. Thus, pcDNA3.1 expression constructs were generated in which Lys-188 was changed to either alanine (K188A) or
glutamic acid (K188E), and the vectors were stably expressed in
XPA⫺/⫺ cells. Coimmunoprecipitation assays were performed
to examine the effects of the Lys-188 mutations on ATR binding to XPA. As shown in Fig. 4B, anti-XPA antibody efficiently
co-immunoprecipitated ATR from whole cell lysates generated
from XPA⫺/⫺ cells complemented with wild-type XPA protein.
Consistent with previous observations, UV-C irradiation
increased the affinity of ATR for XPA but was unnecessary for
the interaction (22). Interestingly, XPA-K188E protein also was
able to co-immunoprecipitate ATR in a similar pattern to that
observed for the wild-type protein, although its affinity seemed
slightly reduced. The K188A mutation, however, completely
abolished the XPA-ATR interaction in both the irradiated and
un-irradiated cells. These results were further confirmed by the
reversed coimmunoprecipitation in which XPA was coimmunoprecipitated by anti-ATR antibody (Fig. 4B).
Effect of K188A Mutation on Nuclear Import of XPA upon UV
Irradiation and DNA Damage Repair—We previously reported
that after DNA damage, XPA translocates from the cytoplasm
to the nucleus in an ATR-dependent manner (17). Thus, an
interesting question is whether the ATR-XPA interaction is
required for XPA nuclear import. To address this question, a
cellular fractionation assay was performed using XPA⫺/⫺ cells
expressing recombinant wild-type XPA (XPA-WT) or XPAK188A mutant. After UV-C irradiation (20 J/m2), wild-type
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XPA is re-distributed from the cytoplasm to the nucleus. However, UV-C irradiation does not affect the cellular distribution
of the XPA-K188A protein (Fig. 4C). These results suggest that
the K188A mutation negatively affects the ability of ATR to
induce nuclear accumulation of XPA in response to DNA damage. The results were further confirmed by an immunofluorescence microscopy assay in which the subcellular localization of
XPA was directly visualized (Fig. 4C). Interestingly, the phosphorylation of XPA at Ser-196 appears to have no effect on XPA
nuclear import. All these suggest that physical interaction
between XPA and ATR, but not Ser-196 phosphorylation, may
play a role in DNA damage-induced XPA nuclear import. It
should be noted that although the total levels of XPA appeared
to be different in cells expressing XPA-WT and mutant, the
effect of total XPA level on the UV-induced subcellular translocation patterns of XPA should be very minimal. To determine the
dependence of NER on the Lys-188-mediated ATR-XPA interaction, XPA-WT or XPA-K188A mutant cells were cultured on glass
coverslips and irradiated through isopore filters to generate localized DNA damage. Damage foci were visualized by immunofluorescence microscopy and measured as a function of repair time. As
shown in Fig. 4D, foci removal is impaired in XPA⫺/⫺ and XPAK188A cells compared with XPA-WT cells, suggesting that the
mutation largely abrogated the repair.
XPA Phosphorylation and DNA Damage Repair—Another
possible role of ATR binding to XPA in cells is to phosphorylate
the NER protein. The ATR-dependent phosphorylation of XPA
previously has been shown to play a role in cell survival after
UV-C irradiation (22). Given the unique role of XPA in NER, we
hypothesized that XPA phosphorylation may play a role in promoting removal of UV photoproducts. Previous experiments in
which ATR kinase activity was inhibited by small interfering
RNA knockdown reduced the repair rate of (6-4) photoproducts ((6-4)PPs) (17); however, most of the lesions were removed
within several hours post-irradiation, which appears to be earlier than XPA phosphorylation (22). This suggests that the
phosphorylation may not be involved in (6-4)PP repair. We,
therefore, reason that XPA phosphorylation might play a role in
promoting the removal of persistent lesions, such as CPDs.
To test the notion, repair of UV-C-induced photoproducts was monitored by immunofluorescence microscopy in
XPA⫺/⫺ cells complemented with either wild-type XPA or
XPA in which serine 196 was replaced by alanine (S196A). As
shown in Fig. 5A, CPD and (6-4)PP foci (stained in red), formed
in the nuclei of cells complemented with XPA-WT protein,
decrease in size and frequency as the recovery time increases up
to 24 h. However, CPD foci are more persistent in nuclei from
XPA-S916A complemented cells. Nuclei from cells transfected
with empty vector alone show little change in CPD focus size or
frequency across time. These results suggest that CPD lesions
are repaired at a slower rate in cells complemented with XPAS196A compared with XPA-WT protein (Fig. 5, A and B). In
agreement with previous results, no substantial difference in
repair rate was observed for (6-4)PPs between cells complemented with wild-type and phosphorylation-deficient XPA
(Fig. 5B). In a parallel DNA repair assay (Fig. 5C), XPA-complemented cells were irradiated with UV-C (20 J/m2) followed by
extraction of the genomic DNA. Equal amounts of purified
VOLUME 284 • NUMBER 36 • SEPTEMBER 4, 2009
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FIGURE 4. Residue Lys-188 is required for XPA-ATR complex formation, XPA nuclear import upon UV damage, and NER. A, ribbon diagram of XPA
minimum DNA-binding domain (PDB code 1D4U), indicating that the identified lysine residue Lys-188 (shown in blue) is located in the helix-turn-helix
motif-containing ATR phosphorylation site serine 196. B, point mutations were generated in the pcDNA-XPA expression construct generating alanine (K188A)
and glutamic acid (K188E) substitutions. The mutated constructs as well as wild-type XPA were stably expressed in XPA⫺/⫺ cells, and their effects on the
XPA-ATR interaction were investigated by coimmunoprecipitation (IP). The K188A mutant protein was unable to coimmunoprecipitate ATR or vice versa from
lysates generated from UV-irradiated or un-irradiated cells. The K188E mutant maintained the interaction between XPA and ATR and exhibited a similar
UV-induced pattern as seen for XPA-WT. The relative amounts of the co-immunoprecipitated ATR were estimated by its ratio to those of the immunoprecipitated protein that were normalized to the loading control IgG. C, XPA cells complemented with wild-type XPA and XPA-K188A were subjected to subcellular
fractionation and immunofluorescence microscopy analysis. The specificity of the fractionation assay is demonstrated by the presence and absence of
cytoplasm-specific and nucleus-specific proteins ␤-actin and PARP (poly(ADP-ribose) polymerase), respectively, in the cytosol and nucleus. D, cells were
irradiated with UV of 50 J/m2 through isopore filters to induce localized DNA damage and then fixed at the indicated times for immunofluorescence analysis
with anti-CPD antibody. Nuclei containing at least one well defined CPD focus were counted as a percentage of total DAPI-stained nuclei and plotted versus
time post-irradiation. At least 50 DAPI-stained nuclei were randomly chosen for the quantification at each time point.

DNA were then immobilized on nylon membrane and probed
with antibody specific for CPDs. Consistently, CPD lesions
were removed more efficiently in cells expressing XPA-WT
compared with cells expressing phosphorylation-deficient
XPA-S196A protein, whereas little repair occurred in XPA cells
transfected with empty vector. These results suggest that XPA
phosphorylation promotes the repair of persistent UV-induced
photolesions. Also importantly, the phosphorylation is dependent on the ATR-XPA interaction as demonstrated in Fig. 5D in
which the XPA phosphorylation was abolished in cells expressing XPA-K188A mutant. Taken together, these results support
the observation on the effects of XPA-K188A mutation on CPD
repair in Fig. 4D.
To determine whether the reduced repair of CPD lesions by
XPA-S196A was because of reduced nuclear translocation, we
SEPTEMBER 4, 2009 • VOLUME 284 • NUMBER 36

performed a cellular fractionation assay to determine the subcellular distribution of XPA-S196A in response to UV-C irradiation. As demonstrated in Fig. 5E, phosphorylation-deficient
XPA-S196A is imported into the nucleus with the same efficiency as wild-type XPA, suggesting that XPA translocation is
not affected by the phosphorylation. The result is consistent
with that determined by the immunofluorescence analysis (Fig.
4C). Taken together, XPA phosphorylation is likely involved in
a mechanism independent of subcellular protein redistribution
to promote repair of persistent DNA lesions.

DISCUSSION
Our previous work has demonstrated that XPA is phosphorylated by the DNA damage checkpoint kinase ATR in response
to UV irradiation at serine residue 196 located in the minimum
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Effects of XPA phosphorylation on repair of cyclobutane pyrimidine dimers. Recombinant pcDNA constructs containing wild-type XPA or
XPA-S196A cDNA were stably expressed in XPA⫺/⫺ cells. A, cells were grown on coverslips and UV-irradiated at 20 J/m2 through isopore filters to induce
localized DNA damage followed by immunofluorescence staining with anti-(6-4)PPs and anti-CPD antibodies at the indicated time points. B, nuclei containing
at least one DNA damage focus were counted as a percentage of total nuclei and plotted versus time post-irradiation. At least 50 DAPI-stained nuclei were
randomly counted for each time point. C, genomic DNA was isolated from cells complemented with wild-type or phosphorylation-deficient XPA after UV-C
irradiation. The DNA was then immobilized on nylon membranes, and total CPDs were detected using mouse-anti-CPD. D, cells expressing recombinants
XPA-WT and XPA-K188A, respectively, were UV-irradiated and then subjected to Western blot analysis of phosphorylated and intact XPA. E, subcellular
distribution of XPA-WT and XPA-S196A after UV-C irradiation was determined by cellular fractionation. ␤-Actin and PARP (poly(ADP-ribose) polymerase),
cytoplasm- and nucleus-specific proteins, respectively, demonstrate the specificity of the assay and serve as loading controls.

DNA-binding domain of XPA (17). In addition, ATR directed
the UV-induced subcellular redistribution of XPA from the
cytosol to the nucleus in both a dose-dependent and time-dependent manner (22). Given the central role of XPA in nucleotide excision repair, an interaction between XPA and ATR may
represent a novel regulatory mechanism for NER to be modulated by DNA damage checkpoints. The dependence of NER on
ATR is further supported by a recent report by Auclair et al.
(23).
In this study we have employed our protein footprinting
approach to map the interaction sites of ATR and XPA. We
probed the surface topology of XPA in complex with ATR and
identified one lysine residue, Lys-188, which is involved in the
ATR-XPA interaction. Lys-188 is located in the N-terminal
helix of the helix-turn-helix motif containing the ATR phosphorylation site Ser-196. In contrast, lysine residue 204 located
in the C-terminal helix of the helix-turn-helix motif is not protected from modification by ATR, suggesting that only the
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N-terminal helix is directly involved in the ATR-XPA interaction. Mutating Lys-188 to alanine effectively abolished the
interaction between XPA and ATR, whereas the K188E substitution had a relatively modest effect on the complex formation.
One explanation for this observation is that ATR is able to
remodel its XPA binding surface and effectively bind the K188E
protein but not the K188A. A second explanation is that Lys188 is not directly in the binding site, but the alanine and glutamic acid mutations to this residue differentially alter the stability of the N-terminal ␣-helix that mediates the XPA-ATR
interaction. Lysine residues are often involved in the formation
of salt bridges that stabilize helical secondary structures. Moreover, the presence of acidic residues in the N terminus are also
known to stabilize the ␣-helices (36 –38). The substitution of
alanine at Lys-188 might destabilize the N-terminal helix of the
XPA helix-turn-helix motif, whereas substitution with glutamic acid may result in an equally or possibly more stable helix
(39, 40). In summary, these results strongly imply a key role for
VOLUME 284 • NUMBER 36 • SEPTEMBER 4, 2009
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persistent DNA-damaging than
(6-4) photoproducts (41). Taken
together, these results suggest that
XPA phosphorylation may play a
role in stimulating NER activity for
removal of persistent DNA damage
through an as yet undetermined
mechanism. This also appears consistent with our previous observation that phosphorylated XPA represents only a small portion of the
cellular pool of XPA (22).
We hypothesized that phosphorylation of XPA may modulate NER
activity by altering the affinity of
XPA for the damage site. Indeed,
FIGURE 6. Modeling analysis of the effects on surface charge distribution from phosphorylation of XPA phosphorylated XPA was shown
at serine residue 196. A surface representation of the DNA-binding domain of XPA (PDB code 1D4U) is shown to associate more tightly with UVat the left with the electrostatic field mapped in red (negative) and blue (positive). A computation model of the damaged chromatin in cells than
DNA-binding domain of XPA phosphorylated at serine 196 is shown at the right with the same mapping of the
electrostatic field. The circle highlights the region of the protein near serine 196 where a large net increase in the wild-type XPA (22). Previous
negative charge is associated with phosphorylation.
NMR data generated by docking
the XPA minimum DNA-binding
the N-terminal ␣-helix of the XPA helix-turn-helix motif in the domain to a ssDNA 9-mer projected a DNA-binding cleft coninteraction with ATR and suggest that Lys-188 mediates the sisting of a series of basic residues aligned across the minimal
effects on this interaction indirectly by modulating the stability DNA-binding domain (42). We generated a computational
of the helix rather than through direct interaction with ATR. It model of the XPA minimal DNA-binding domain to obtain
should be noted, however, that because ⬃30% ATRIP remained insight into how phosphorylation of serine 196 could affect the
bound to the ATR assayed in this study, the involvement of surface charge distribution of the protein. Fig. 6 illustrates that
Ser-196 phosphorylation induces an accumulation of negative
ATRIP in the ATR-XPA interaction is also possible.
The significance of the ATR-XPA interaction has been charge along the surface of the helix-turn-helix motif. However,
shown by its requirement for XPA nuclear import in response our computational model did not predict any significant
to UV irradiation of the cells (Fig. 4). Because XPA is an indis- change in the positive charge distribution of the DNA-binding
pensable factor for NER and the nuclear availability of XPA is cleft after Ser-196 phosphorylation. Although we did not
critical for NER, it is reasonable to expect that NER may depend observe any change in surface charge distribution for the proon ATR-XPA interaction. Indeed our result indicates that the posed DNA-binding cleft, the current structural model of the
nucleotide excision repair of UV-induced photolesions XPA-DNA interaction is based on XPA interacting with an
requires the ATR-XPA interaction in cells. There are at least ssDNA substrate. It is well documented that XPA binds damtwo possible scenarios in which XPA nuclear translocation and, aged dsDNA, and moreover, our previous study indicates that
thus, NER could depend on ATR-XPA interaction. First, the XPA interacts most efficiently with a substrate containing a
interaction could occur in the nucleus, which reduces the ssDNA-dsDNA junction. Thus, additional stabilizing contacts
nuclear concentration of free XPA. The depletion of free XPA between DNA and XPA may be present that were not identified
in the nucleus disrupts the concentration balance across the in the NMR study. The need for further analysis of the XPA
nuclear membrane and subsequently allows more XPA to be interaction with ssDNA-dsDNA junction substrates is highimported into the nucleus driven by favorable free energy. In lighted by multiple reports supporting the interaction as the
the second scenario, XPA could form a complex with ATR in most probable DNA structure in which XPA would be prethe cytoplasm and then be imported into the nucleus across the sented in vivo. Indeed, the recruitment of XPF-ERCC1 complex
by XPA after strand opening by TFIIH supports a model of XPA
nuclear membrane in the complex form.
It is obvious that ATR-XPA complex formation is also binding at or near the ssDNA-dsDNA junction in the pre-incirequired for the phosphorylation of XPA. Phosphorylation of sion complex (3, 9, 43– 45).
Another possible mechanism for increased chromatin assoXPA at serine 196 has previously been shown to moderately
promote cell survival after UV-C irradiation (22). Given that ciation after Ser-196 phosphorylation could be related to the
the only known function for XPA is in NER, we assayed UV-C- increased affinity of XPA with respect to its binding partners.
induced photoproducts removal to investigate the role of XPA Our electrostatic model clearly indicates that phosphorylation
phosphorylation in NER. We found that XPA⫺/⫺ cells comple- of Ser-196 induces significant accumulation of negative charge
mented with XPA-S196A displayed a slower repair rate for on the helix-turn-helix motif. This motif, in addition to DNA
CPD photoproducts when compared with wild-type XPA. By binding, is located in close proximity to both the RPA70 and
contrast, no effect has been observed for repair of (6-4) photo- TFIIH interaction domains on XPA (8). Increasing the XPA
products. It has been well established that CPD is much more affinity for RPA70 and/or TFIIH could, therefore, modulate the
SEPTEMBER 4, 2009 • VOLUME 284 • NUMBER 36
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association of XPA with the damage site in a manner independent of its affinity for DNA.
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